Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.3%

1 terminated out of 19 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

32%

6 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

88% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (6)
P 1 (1)
P 2 (1)
P 3 (6)

Trial Status

Recruiting7
Completed7
Not Yet Recruiting3
Terminated1
Unknown1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT07545746Phase 2Not Yet Recruiting

Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya

NCT06147388Recruiting

Regression of Cervical Precancerous Lesions and Associated Risk Factors

NCT05413811Not ApplicableCompleted

Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV

NCT07146152Not ApplicableNot Yet RecruitingPrimary

Empowering Women - Shared Decision Making in Managing Cervical Precancer

NCT02956031Recruiting

Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.

NCT05413798Not ApplicableRecruiting

Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa

NCT04422366Phase 3Recruiting

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

NCT05371353Recruiting

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

NCT04895020Phase 3Recruiting

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

NCT05027776Phase 3Recruiting

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

NCT06210074Not ApplicableNot Yet RecruitingPrimary

Performance of Tampons as a Biospecimen Collection Tool for the Detection of Human Papillomavirus in a Colposcopy Setting

NCT05372016Phase 3Completed

Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

NCT04687267CompletedPrimary

Conservative Management of CIN2 Lesions and Biomarkers Evaluation

NCT05584332Phase 3Terminated

A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females

NCT01881659Unknown

Cervical Cancer Screening With Human Papillomavirus Testing

NCT03177863Not ApplicableCompletedPrimary

Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age

NCT04425291Phase 3Completed

Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

NCT02405533Not ApplicableCompleted

Phase II Evaluation of AHCC for the Eradication of HPV Infections

NCT03676101Phase 1Completed

Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Showing all 19 trials

Research Network

Activity Timeline